Bidirectional two sample Mendelian randomization study on causal effects of gut microbiota and ferroptosis on Kawasaki disease with mediation analysis
Open Access
- 15 September 2025
- journal article
- research article
- Published by Springer Nature in Discover Medicine
- Vol. 2 (1) , 1-11
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activityCancer Letters, 2024
- Kawasaki disease: contemporary perspectivesThe Lancet Child & Adolescent Health, 2024
- Human Gut Microbiota in Cardiovascular DiseaseComprehensive Physiology, 2024
- The cell biology of ferroptosisNature Reviews Molecular Cell Biology, 2024
- Ferroptosis in cardiovascular diseaseBiomedicine & Pharmacotherapy, 2023
- Microbiome-based interventions to modulate gut ecology and the immune systemMucosal Immunology, 2022
- The molecular and metabolic landscape of iron and ferroptosis in cardiovascular diseaseNature Reviews Cardiology, 2022
- Gut microbiota and inflammatory bowel diseaseWIREs Mechanisms of Disease, 2021
- Mendelian randomisation for mediation analysis: current methods and challenges for implementationEuropean Journal of Epidemiology, 2021
- Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki diseaseEuropean Journal of Human Genetics, 2021